Global Met-Enkephalin Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Met-Enkephalin Market Insights, Forecast to 2034
Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF),is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.
Global Met-Enkephalin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Met-Enkephalin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Met-Enkephalin key manufacturers include Neuromics, Cayman Chemical, Genscript, Thermo Scientific, Abcam, Aapptec, Abbiotec and Bachem, etc. Neuromics, Cayman Chemical, Genscript are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Met-Enkephalin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Met-Enkephalin market and estimated to attract more attentions from industry insiders and investors.
Met-Enkephalin can be divided into Human, Mouse, Rat and Rabbit, etc. Human is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Met-Enkephalin is widely used in various fields, such as Scientific Research, Medical and Others,, etc. Scientific Research provides greatest supports to the Met-Enkephalin industry development. In 2022, global % sales of Met-Enkephalin went into Scientific Research filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Met-Enkephalin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Met-Enkephalin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Neuromics
Cayman Chemical
Genscript
Thermo Scientific
Abcam
Aapptec
Abbiotec
Bachem
Segment by Type
Human
Mouse
Rat
Rabbit
Scientific Research
Medical
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Met-Enkephalin plant distribution, commercial date of Met-Enkephalin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Met-Enkephalin introduction, etc. Met-Enkephalin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Met-Enkephalin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Met-Enkephalin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Met-Enkephalin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Met-Enkephalin key manufacturers include Neuromics, Cayman Chemical, Genscript, Thermo Scientific, Abcam, Aapptec, Abbiotec and Bachem, etc. Neuromics, Cayman Chemical, Genscript are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Met-Enkephalin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Met-Enkephalin market and estimated to attract more attentions from industry insiders and investors.
Met-Enkephalin can be divided into Human, Mouse, Rat and Rabbit, etc. Human is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Met-Enkephalin is widely used in various fields, such as Scientific Research, Medical and Others,, etc. Scientific Research provides greatest supports to the Met-Enkephalin industry development. In 2022, global % sales of Met-Enkephalin went into Scientific Research filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Met-Enkephalin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Met-Enkephalin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Neuromics
Cayman Chemical
Genscript
Thermo Scientific
Abcam
Aapptec
Abbiotec
Bachem
Segment by Type
Human
Mouse
Rat
Rabbit
Segment by Application
Scientific Research
Medical
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Met-Enkephalin plant distribution, commercial date of Met-Enkephalin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Met-Enkephalin introduction, etc. Met-Enkephalin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Met-Enkephalin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices